FIELD: medicine. SUBSTANCE: course of discrete plasmapheresis is carried out at pregnant having primary antiphospholipid syndrome. Treatment course has 6-12 seances, 400-600 ml of plasma being removed per each seance. Treatment course is repeated when antiphospholipid antibodies acculumate in blood. EFFECT: increases efficiency of treatment. 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR TREATMENT OF RECURRENT PREGNANCY LOSS RELATED TO RETROCHORIAL HEMATOMA | 2017 |
|
RU2668715C1 |
| METHOD FOR EVALUATING THE EFFECTIVENESS OF TREATMENT WITH INTRAVENOUS IMMUNOGLOBULINS IN FEMALE PATIENTS WITH HABITUAL MISCARRIAGE AND CIRCULATION OF ANTI-PHOSPHOLIPID ANTIBODIES | 2021 |
|
RU2775311C1 |
| METHOD FOR DETERMINING LUPUS ERYTHEMATOSUS ANTICOAGULANT AVAILABILITY | 1999 |
|
RU2181203C2 |
| METHOD OF TREATMENT OF WOMEN WITH CYTOMEGALOVIRAL INFECTION IN CUSTOMARY NONBEARING PREGNANCY | 1996 |
|
RU2139066C1 |
| METHOD FOR TREATING ANTIPHOSPHOLIPID SYNDROME | 2001 |
|
RU2188680C1 |
| METHOD FOR PREPARING AND CONDUCTING THE PREGNANCY IN WOMEN WITH HERPES VIRAL INFECTION | 2005 |
|
RU2283141C1 |
| METHOD FOR PREVENTING SEVERE PREGNANCY COMPLICATIONS IN THROMBOPHILIC PATIENTS | 2008 |
|
RU2367446C1 |
| METHOD FOR TREATING ANTIPHOSPHOLIPID SYNDROME | 2001 |
|
RU2232028C2 |
| METHOD FOR EVALUATING THE EFFECTIVENESS OF TREATMENT WITH INTRAVENOUS IMMUNOGLOBULINS IN FEMALE PATIENTS WITH HABITUAL MISCARRIAGE AND CIRCULATION OF ANTI-PHOSPHOLIPID ANTIBODIES | 2021 |
|
RU2783003C1 |
| DRUG AND METHOD OF CORRECTION OF HEMOSTASIS INDICES IN INCOMPLETE PREGNANCY | 1996 |
|
RU2146527C1 |
